Literature DB >> 10407166

Kainic acid-induced seizure upregulates Na(+)/myo-inositol cotransporter mRNA in rat brain.

M Nonaka1, E Kohmura, T Yamashita, A Yamauchi, T Fujinaka, T Yoshimine, M Tohyama, T Hayakawa.   

Abstract

A major organic osmolyte, myo-inositol protects cells from perturbing effects of high intracellular concentrations of electrolytes. Myo-inositol is accumulated into cells through Na(+)/myo-inositol cotransporter (SMIT). In order to investigate the regulation of SMIT in generalized seizure, we employed Northern blot analysis and in situ hybridization to study the changes in SMIT mRNA expression in kainic acid-injected rats. Northern blot analysis demonstrated that SMIT mRNA began to increase in the brain 2 h after onset of seizure, and peaked at 12 h. In situ hybridization revealed rapid increase of SMIT mRNA (2 h of seizure) in the CA3 hippocampal pyramidal cells and in the dentate granular cells. Then, at 4-6 h SMIT mRNA expression was observed in the other limbic structure such as amygdala and piriform cortex. Finally, in neocortex and in CA1 pyramidal cells, SMIT mRNA was slowly increased and peaked at 12 h. Microautoradiogram demonstrated that cells expressed SMIT mRNA were mainly neurons. These results suggest that SMIT mRNA is upregulated by kainic acid-induced seizure primarily in structures involved in seizure activity. Copyright 1999 Published by Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10407166     DOI: 10.1016/s0169-328x(99)00127-8

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  7 in total

1.  Physiologic variability of single-voxel proton MR spectroscopic measurements at 3T.

Authors:  R Mark Wellard; Regula S Briellmann; Claire Jennings; Graeme D Jackson
Journal:  AJNR Am J Neuroradiol       Date:  2005-03       Impact factor: 3.825

2.  Hippocampal betaine/GABA transporter mRNA expression is not regulated by inflammation or dehydration post-status epilepticus.

Authors:  Nicole M Rowley; Misty D Smith; John G Lamb; Arne Schousboe; H Steve White
Journal:  J Neurochem       Date:  2011-02-09       Impact factor: 5.372

3.  Studies of myo-inositol and plasmalogen metabolism in rat brain.

Authors:  Beth Hoffman-Kuczynski; Nicholas V Reo
Journal:  Neurochem Res       Date:  2004-04       Impact factor: 3.996

4.  Spectroscopic metabolic abnormalities in mTLE with and without MRI evidence for mesial temporal sclerosis using hippocampal short-TE MRSI.

Authors:  Susanne G Mueller; Kenneth D Laxer; Joyce Suhy; Ria C Lopez; Derek L Flenniken; Michael W Weiner
Journal:  Epilepsia       Date:  2003-07       Impact factor: 5.864

5.  The protective effect of myo-inositol on hippocamal cell loss and structural alterations in neurons and synapses triggered by kainic acid-induced status epilepticus.

Authors:  Nato Kotaria; Maia Kiladze; Mzia G Zhvania; Nadezhda J Japaridze; Tamar Bikashvili; Revaz O Solomonia; Tamar Bolkvadze
Journal:  Cell Mol Neurobiol       Date:  2013-04-09       Impact factor: 5.046

6.  Myoinositol Attenuates the Cell Loss and Biochemical Changes Induced by Kainic Acid Status Epilepticus.

Authors:  Lia Tsverava; Tamar Lordkipanidze; Eka Lepsveridze; Maia Nozadze; Marina Kikvidze; Revaz Solomonia
Journal:  Biomed Res Int       Date:  2016-08-23       Impact factor: 3.411

Review 7.  Myo-Inositol and Its Derivatives: Their Emerging Role in the Treatment of Human Diseases.

Authors:  Dhani Raj Chhetri
Journal:  Front Pharmacol       Date:  2019-10-11       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.